Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer |
| |
Authors: | Zbigniew Jab?onowski Edyta Reszka Jolanta Gromadzińska Wojciech W?sowicz Marek Sosnowski |
| |
Affiliation: | 1.1st Department of Urology, Medical University of Lodz, Poland;2.Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland |
| |
Abstract: | IntroductionThe aim of the study was to examine the frequency of methylation status in promoter regions of p16 and DAPK genes in patients with non-invasive bladder cancer.Material and methodsForty-two patients (92.9% men, 73.8% smokers, 71.4% T1G1, 19.1% T1G2, 9.5% T1G3) and 36 healthy controls were studied. Isolation of genomic DNA from blood serum and methylation-specific PCR (MSP) were applied. Methylation status – methylated and unmethylated promoter regions of p16 and DAPK genes were analysed.ResultsSeventeen out of 42 patients (40.5%) had the methylated p16 gene, while methylation of the DAPK gene was seen in 27 of 42 cases (64.3%). In 12 patients (28.6%) both analysed genes were methylated. A statistically significant (p = 0.046) higher frequency of DAPK gene methylation (71.4%) was observed in patients with lower grade (G1) bladder cancer.ConclusionsDetection of the aberrant hypermethylation of DAPK and p16 genes in blood DNA from non-invasive bladder cancer patients might offer an effective means for earlier auxiliary diagnosis of the malignancy. |
| |
Keywords: | non-invasive bladder cancer DAPK p16 hypermethylation methylation-specific PCR |
|
|